Align Technology, Inc. Stock

Equities

ALGN

US0162551016

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
310.5 USD -1.05% Intraday chart for Align Technology, Inc. +3.04% +13.32%
Sales 2024 * 4.11B Sales 2025 * 4.5B Capitalization 23.61B
Net income 2024 * 538M Net income 2025 * 630M EV / Sales 2024 * 5.41 x
Net cash position 2024 * 1.38B Net cash position 2025 * 1.5B EV / Sales 2025 * 4.91 x
P/E ratio 2024 *
43.5 x
P/E ratio 2025 *
36.7 x
Employees 21,610
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.05%
1 week+3.04%
Current month-5.31%
1 month-2.75%
3 months+18.46%
6 months+22.39%
Current year+13.32%
More quotes
1 week
297.17
Extreme 297.17
327.49
1 month
296.50
Extreme 296.5
331.64
Current year
250.28
Extreme 250.28
335.40
1 year
176.34
Extreme 176.34
413.20
3 years
172.05
Extreme 172.05
737.45
5 years
127.88
Extreme 127.88
737.45
10 years
43.27
Extreme 43.27
737.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 15-05-31
Director of Finance/CFO 57 16-11-09
Chief Tech/Sci/R&D Officer 59 13-12-01
Members of the board TitleAgeSince
Director/Board Member 72 06-01-31
Chief Executive Officer 65 15-05-31
Director/Board Member 58 Dec. 04
More insiders
Date Price Change Volume
24-04-25 310.5 -1.05% 1,647,413
24-04-24 313.8 +0.61% 1,106,124
24-04-23 311.9 +3.68% 621,458
24-04-22 300.8 +0.62% 446,836
24-04-19 299 -0.78% 520,396

Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT

More quotes
Align Technology, Inc. specializes in the design, manufacturing and marketing of dental and medical devices. Net sales break down by family of products as follows: - clear aligners (82.8%): sold under the brand name Invisalign; - intra-oral scanners (17.2%): iTero. The group also offers scanner services. Net sales are distributed geographically as follows: the United States (43.1%), Switzerland (30.3%), and other (26.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
313.8 USD
Average target price
330.9 USD
Spread / Average Target
+5.45%
Consensus